Related Experiment Video
Updated: Jun 2, 2026
05:02
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Inflammatory breast cancer: what progress have we made?
Shaheenah Dawood1, Massimo Cristofanilli
1Department of Medical Oncology, Dubai Hospital, Dubai Health Authority, United Arab Emirates. Shaheenah@post.harvard.edu
Oncology (Williston Park, N.Y.)
|May 10, 2011
Summary
Inflammatory breast cancer (IBC), a rare and aggressive breast cancer subtype, has seen improved survival due to a multidisciplinary approach. Recent research highlights progress in its epidemiology, molecular biology, and clinical management.
Area of Science:
- Oncology
- Medical Research
Background:
- Inflammatory breast cancer (IBC) is a rare, aggressive form of locally advanced breast cancer (LABC).
- Historically, IBC had a poor prognosis, but a multidisciplinary approach has improved survival.
- Diagnosis requires clinical suspicion and pathological confirmation of invasive cancer.
Purpose of the Study:
- To review advancements in Inflammatory Breast Cancer (IBC) research over the past decade.
- To focus on progress in epidemiology, molecular biology, and clinical management of IBC.
Main Methods:
- Literature review of recent studies on Inflammatory Breast Cancer (IBC).
- Analysis of epidemiological data, molecular findings, and clinical management strategies.
- Synthesis of research progress over the last ten years.
Main Results:
- Significant progress has been made in understanding IBC epidemiology and molecular drivers.
- Advances in pre-operative chemotherapy, surgery, and radiation therapy have enhanced multidisciplinary management.
- Improved diagnostic criteria and treatment protocols contribute to better patient outcomes.
Conclusions:
- The multidisciplinary approach has transformed IBC management, improving survival rates.
- Continued research in IBC's molecular biology and epidemiology is crucial for further therapeutic development.
- Recent decade advancements offer new hope for patients with this aggressive breast cancer subtype.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...